companydata.dkAMPLEXA GENETICS A/S: Financial statements 2023
CVR: 29428441
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,224,941 and a net result of DKK -3,131,078 compared with DKK -2,282,128 the year before. That is a decrease of 41.3% compared with the year before. Equity amounted to DKK 2,378,310. The solvency ratio was 15.9%. The company had 15 employees in the financial year.
- Gross Profit
- 3,224,941 kr.
- Profit/Loss
- -3,131,078 kr.
- Equity
- 2,378,310 kr.
- Total Assets
- 14,975,575 kr.
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3.2 mio. | -3.1 mio. | 2.4 mio. | 15 |
| 2022 | - | 5.5 mio. | -2.3 mio. | -14.5 mio. | 14 |
| 2021 | - | 20.3 mio. | 12.3 mio. | -12.2 mio. | 13 |
| 2020 | - | 12.4 mio. | 5.9 mio. | -24.5 mio. | 7 |
| 2019 | - | 2.8 mio. | -1.5 mio. | -30.4 mio. | 7 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
AMPLEXA GENETICS A/S has published its annual report for 2022. Gross profit came to DKK 5,494,691, and the net result was DKK -2,282,128.
As of April 17, 2023, is registered as an owner of AMPLEXA GENETICS A/S with an ownership share of 25%.
As of March 16, 2023, Ulf Bech Christensen has joined the board of directors of AMPLEXA GENETICS A/S.
As of March 16, 2023, Nils Christian Jensen has left the board of directors of AMPLEXA GENETICS A/S.
As of March 16, 2023, Leif Abrahamsen has left the board of directors of AMPLEXA GENETICS A/S.
As of March 16, 2023, Charles Steven Glavas has left the board of directors of AMPLEXA GENETICS A/S.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.